SlideShare a Scribd company logo
FORWARD IMRT
DR. AMRITA RAKESH
DNB RESIDENT
DEPT. OF RADIATION ONCOLOGY
BMCHRC,JAIPUR.
Introduction
• Prime objective for the planning : to deliver uniform dose
throughout the target volume, with adequate tumour coverage
and minimise dose to normal tissue.
• Evolution of treatment planning : conventional to 3D conformal
to IMRT.
• Most patients with early breast cancer undergo breast-
conserving treatment consisting of wide excision and post-
operative whole-breast radiotherapy. This form of
postoperative radiotherapy reduces the risk of local recurrence
and results in long-term survival similar to that obtained
with mastectomy.
• Thus, postoperative breast therapy is a standard treatment
• In recent years, the field-in-field (FIF) technique (i.e.,
Forward IMRT) has become a widely performed
method of administering tangential whole-breast
radiotherapy.
• The use of the FIF technique permits reductions in
the size of the high-dose region and better
homogeneity index.
Why homogeneity Matters?
Whole breast irradiation often leads to both acute and
long term toxicities such as :
• moist desquamation
• pain
• breast discomfort
• breast hardness
Many studies shown that toxicities were associated with
dose inhomogeneity (hot spots).
• Pignol et al
358 patients were randomized in a multicenter
double-blind clinical trial to either 2-dimentional
treatment planning or IMRT planning with improved
dose homogeneity.
The incidence of moist desquamation in the IMRT
group was 31.2% vs 47.8%, p=0.002
Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to
reduce acute radiation dermatitis. J Clin Oncol. 2008 May 1;26(13):2085-92.
• Donovan et al
306 patients were randomized to 2D or 3D IMRT.
After 5 years 240 patients data was available for
analysis.
The 2D arm patients were 1.7 times more likely to
have changes in breast appearance than IMRT
group
Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus
intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007 Mar;82(3):254-
64.
Breast V105%
and V110%
were significantly associated
with increase in acute skin toxicity
• V110%
< 200cc: 31% grade >2 skin toxicity
• V110%
> 200cc: 61% grade >2 skin toxicity
Vicini et.al. Int.J. Radiat Oncol Biol Phys 54: 1336-1344; 2002.
• The use of IMRT in the treatment of the whole
breast results in a significant decrease in acute
dermatitis, edema, and hyperpigmentation and a
reduction in the development of chronic breast
edema compared with conventional wedge-based
WBRT.
Harsolia et.al. Int.J. Radiat Oncol Biol Phys 68: 1375-1380; 2007
• Inverse Planning:
The user specifies the
goals, the computer then
adjusts the beam
parameters to achieve the
desired outcome.
• Forward Planning:
The beam geometry i.e
beam angle, shape,
modifier, weights etc. is
first defined, followed by
calculation of the 3D dose
distribution.
IMRT for Breast
Radiotherapy
Many beams with different angles may help with
dose conformality, but will lead to higher doses in
lung, heart and contralateral breast
Tangential beams provide best lung, heart and
contralateral breast sparing.
FIELD-IN-FIELD
TECHNIQUE
• Comprises of two tangential open fields and multiple
subfields to achieve desired homogeneity.
• An open beam configuration is first calculated
and evaluated.
• 4+ subfields per gantry angle are used to produce an
optimal breast plan.
• No wedges.
FORWARD PLANNING
Subfields
• Generally have 1 lung block and 3 additional subfields per
gantry angle.
• Lung block is formed by fitting the MLC’s to the shape of
the lung. Aids in lateral hot spots.
• Additional subfields are generated by manually fitting
MLC’s to “hot” areas. Ex. 115%, 110%, etc…
• Lung block
• manual fitting of MLC’s to “hot” areas
Weighting of Subfields
• Generally, the open beam portion receives ~ 80%
of the dose while the subfields contribute ~20%.
• This makes FP IMRT similar to conventional
treatment .
• Minimizes effects of patient movement on target
coverage.
• Conventional breast plans are generally normalized
to 97% .
• Normalization for IMRT plans are based on
coverage.
Determination of the optimal method for the field-in-field
technique in breast tangential radiotherapy
Hidekazu Tanaka, Shinya Hayashi, and Hiroaki Hoshi
J Radiat Res. 2014 Jul; 55(4): 769–773.
• Several studies have reported the usefulness of the
field-in-field (FIF) technique in breast radiotherapy.
However, the methods for the FIF technique used in
these studies vary.
• There were no reports of comparisons among FIF
techniques.
• This study, classified the methods used for the FIF technique
into three categories :
• The single pair of subfields method -
• In the SSM, each main field was copied as a pair of subfields.
• The MLCs were manipulated to shield the areas of the breast
receiving any dose (mainly at 105–107% of the prescription
dose).
• The dose to shield the MLCs was determined such that the
isodose cloud disappears.
• This method was composed of four fields, including the main
fields.
• The multiple pairs of subfields method -
• Three pairs of subfields were generated.
• The MLCs were set to block the dose level at 1–
2% lower than the maximum dose (Dmax), and
this was followed by a 3–5% dose reduction
(mainly at 102–105% of the prescription dose).
• This method comprised eight fields, including the
main fields.
• The alternate subfields method -
• First, the medial main field was copied as the first
subfield.
• The MLCs were set to block the dose level at 1–2%
lower than the Dmax.
• Dose calculation was performed. The beam weight
of this subfield was added until the dose cloud
disappeared.
• Second, the lateral main field was copied as the
second subfield.
• The MLCs were set to block the dose level at 2–
3% lower than the dose blocked at the first
subfield.
• Dose calculation was performed again, and the
beam weight of this subfield was added until the
dose cloud disappeared.
• Finally, the medial main field was copied again as the
third subfield.
• The MLCs were set to block the dose level at 2–3%
lower than the dose blocked at the second subfield.
• After recalculation, the beam weight of this subfield
was added until the dose cloud disappeared.
• This method was comprised of five fields, including
the main fields.
Beam's eye view for typical
subfield. The subfield was
manipulated to shield the
areas of the breast receiving
any dose cloud.
• The Dmax to the PTV and the volumes of the PTV
receiving 100% and 95% of the prescription dose
(V100% and V95%, respectively) were calculated.
• The homogeneity index (HI) was calculated.
• RESULTS:
• This planning study included 51 patients with early
stage breast cancer: 20 with right-sided breast
cancer and 31 with left-sided breast cancer.
• The median age of the patients was 53 years
(range, 26–76 years).
Table
Average of dose parameters of PTV for each method
SSM (± SD) MSM (± SD) ASM (± SD)
Dmax 52.5 (± 0.7)52.2 (± 0.6)52.2 (± 0.7)
V100% 52.6 (± 16.7) 48.7 (± 14.9) 60.3 (± 14.2)
V95% 93.7 (± 4.2)93.2 (± 4.1)94.1 (± 3.5)
• The average V100% with ASM was
significantly higher than that with SSM and
MSM
• The ASM outperformed the SSM and MSM for two
possible reasons:
• First is that the number of subfields used is more
suitable for the population under study. When the
number of subfields is large, the dose to the PTV decreases, but
when the number of subfields is small, the full range of
advantages of the FIF cannot be fully obtained.
• The biggest advantage of the ASM is its ability to
perform dose calculation each time a subfield is
added.
Key note :
• Radiotherapy planning with SSM required a relatively short
time, because only a few subfields need to be generated.
• Because SSM is the simplest of the three methods, it
should be the method of choice for patients with small
breasts.
• The method most commonly reported is the one in which
multiple pairs of subfields are used. This method was
classified as MSM. The planning time is longer for this
method because of the high number of subfields.
• MD Anderson Cancer Centre group introduced in terms
of number of subfields, fewer subfields than MSM but
more than SSM. This method was classified as ASM.
• The most significant feature of this method is the
recalculation each time when creating subfields, and the
addition of subfields alternately.
• Of note, patients in the thin breast group derived similar
benefit with ASM and SSM.
• ASM resulted in better dose distribution regardless of
the breast size.
Nagoya J. Med. Sci. 77. 339 ~ 345, 2015
Evaluation of the field-in-field technique with lung blocks
for breast tangential radiotherapy
Hidekazu Tanaka et al.
• This study evaluated the FIF technique with lung
blocks for breast tangential radiotherapy.
• Compared to irradiation with physical wedges
(PWs), the use of the FIF technique permits
reductions in the size of the high-dose region.
• The impact of respiratory motion is smaller with the
use of the FIF technique than with the use of PWs.
• Several authors reported the advantages of lung-
blocked subfields, which help to reduce the dose
received by the lungs.
• However, the use of multileaf collimators (MLCs) to
block the lungs also results in blockade of some
parts of the planning target volume (PTV). This
could decrease the doses delivered to the PTV.
• In this study,16 patients with early-stage breast
cancer, including 9 patients with right-sided cancer
and 7 patients with left-sided breast cancer.
• Two opposed tangential fields were created without
PWs.
• The open field was copied as the subfields & on the
beam’s eye view, the MLCs were set to block the
hotspots.
• Then, dose calculation was performed. The beam
weight of this subfield was increased until the dose
cloud disappeared.
• The volumes of the ipsilateral lung receiving 20, 30,
and 40 Gy (V20Gy, V30Gy, and V40Gy,
respectively) were calculated.
• The volumes of the PTV receiving 100 and 95% of
the prescription dose (V100% and V95%,
respectively) and the mean dose (Dmean) to the
PTV were also calculated.
• The amounts of change in the FIF plan and PWs
were evaluated.
• In this study, lung blocks were useful for reducing
the dose delivered to the lungs, but a simultaneous
decrease in the PTV was observed.
• FIF plan was advantageous over the use of physical
wedges.
ique by comparing it with the electronic compensator, varian enh
(a) Main field without multileaf collimator (MLC) blocking.
(b)drawing MLCs to block 112 % isodose cloud
(c) drawing MLCs to block out 106 % (d) drawing MLCs to block out 102%
FIF gave favourable results for all aspects
when compared with other plans.
The “skin flash” problem in
Inverse Problem
• Conventional : margin added
to field edge to allow for
uncertainties.
• IMRT : intensity remains
“zero” outside PTV. No skin
flash
• So, previously tissue equivalent material where
added during planning over the breast, and then
plan were made. So, in actual setup, when MLCs
opened up, actual PTV used to be in air.
• But now, after forward planning, MLCs are opened
to desired width in air, to allow “skin flash”.
• To sum up:
• Conformality adaptions are limited
• Tangential beams are used for main field , as increasing number
of beams will increase lung dose.
• As main field is copied and subfields created to adjust beam
parameters,and then we do dose calculation- so, it is forward
planning.
• Dose homogeneity is improved.
• Less time taking.
• Simple planning.
THANK YOU…
Next Topic : APBI by Dr. Shuchita

More Related Content

What's hot

Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)
Nik Noor Ashikin Nik Ab Razak
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
Sasikumar Sambasivam
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapyfondas vakalis
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
RANJITH C P
 
Imrt Treatment Planning And Dosimetry
Imrt Treatment Planning And DosimetryImrt Treatment Planning And Dosimetry
Imrt Treatment Planning And Dosimetryfondas vakalis
 
Motion Management in Radiation Therapy
Motion Management in Radiation TherapyMotion Management in Radiation Therapy
Motion Management in Radiation Therapy
Teekendra Singh Faujdar
 
Starting out with DIBH
Starting out with DIBH Starting out with DIBH
Starting out with DIBH
SGRT Community
 
Beam modifying devices 1 Radiophysics
Beam modifying devices 1 RadiophysicsBeam modifying devices 1 Radiophysics
Beam modifying devices 1 Radiophysics
DrAyush Garg
 
Icru 58.
Icru 58.Icru 58.
Icru 58.
anju k.v.
 
3DCRT and IMRT
3DCRT and IMRT3DCRT and IMRT
3DCRT and IMRT
Kiron G
 
4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
Parminder S. Basran
 
Total skin electron irradiation
Total skin electron irradiation Total skin electron irradiation
Total skin electron irradiation
Rupon Bhowmik
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
Kiran Ramakrishna
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
 
Image guided radiation therapy
Image guided radiation therapyImage guided radiation therapy
Image guided radiation therapy
Swarnita Sahu
 
Evaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planningEvaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planning
Amin Amin
 
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptxQUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
SuryaSuganthan2
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
Kiran Ramakrishna
 
3 dcrt
3 dcrt3 dcrt
Stereotactic body radiotherapy
Stereotactic body radiotherapyStereotactic body radiotherapy
Stereotactic body radiotherapy
Nanditha Nukala
 

What's hot (20)

Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)Dose Distribution Measurement (part 1)
Dose Distribution Measurement (part 1)
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapy
 
Concept of bed in radiobiology
Concept of bed in radiobiologyConcept of bed in radiobiology
Concept of bed in radiobiology
 
Imrt Treatment Planning And Dosimetry
Imrt Treatment Planning And DosimetryImrt Treatment Planning And Dosimetry
Imrt Treatment Planning And Dosimetry
 
Motion Management in Radiation Therapy
Motion Management in Radiation TherapyMotion Management in Radiation Therapy
Motion Management in Radiation Therapy
 
Starting out with DIBH
Starting out with DIBH Starting out with DIBH
Starting out with DIBH
 
Beam modifying devices 1 Radiophysics
Beam modifying devices 1 RadiophysicsBeam modifying devices 1 Radiophysics
Beam modifying devices 1 Radiophysics
 
Icru 58.
Icru 58.Icru 58.
Icru 58.
 
3DCRT and IMRT
3DCRT and IMRT3DCRT and IMRT
3DCRT and IMRT
 
4dct (2012)
4dct (2012)4dct (2012)
4dct (2012)
 
Total skin electron irradiation
Total skin electron irradiation Total skin electron irradiation
Total skin electron irradiation
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
 
Image guided radiation therapy
Image guided radiation therapyImage guided radiation therapy
Image guided radiation therapy
 
Evaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planningEvaluation of radiotherapy treatment planning
Evaluation of radiotherapy treatment planning
 
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptxQUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
QUALITY ASSURANCE IN LINAC AND CYBERKNIFE.pptx
 
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
 
3 dcrt
3 dcrt3 dcrt
3 dcrt
 
Stereotactic body radiotherapy
Stereotactic body radiotherapyStereotactic body radiotherapy
Stereotactic body radiotherapy
 

Similar to Forward imrt in breast radiotherapy

Accelerated partial breast irradiation
Accelerated partial breast irradiationAccelerated partial breast irradiation
Accelerated partial breast irradiation
Himanshu Mekap
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiation
Sabari Kumar
 
Overview of ART in lung cancer
Overview of ART in lung cancerOverview of ART in lung cancer
Overview of ART in lung cancer
Naveen Mummudi
 
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approach
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approachImmobilization and setup for Prone Breast Radiotherapy- A Therapist approach
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approach
Teekendra Singh Faujdar
 
Adjuvant radiotherapy of regional lymph nodes in breast
Adjuvant radiotherapy of regional lymph nodes in breastAdjuvant radiotherapy of regional lymph nodes in breast
Adjuvant radiotherapy of regional lymph nodes in breast
Kiran Ramakrishna
 
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
DrAnkitaPatel
 
MOULD BRACHYTHERAPY LIP
MOULD BRACHYTHERAPY LIPMOULD BRACHYTHERAPY LIP
MOULD BRACHYTHERAPY LIP
Kanhu Charan
 
Radiotherapy Breast Cancer
Radiotherapy Breast CancerRadiotherapy Breast Cancer
Radiotherapy Breast Cancer
Mohamed Ali Morsy
 
Cervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniquesCervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniques
Animesh Agrawal
 
hypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptxhypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptx
svmmcradonco1
 
Unscheduled rt interruptions
Unscheduled rt interruptionsUnscheduled rt interruptions
Unscheduled rt interruptions
HEBAGOMAA1984
 
Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast Cancer
Dr.T.Sujit :-)
 
RT in early breast.pptx
RT in early breast.pptxRT in early breast.pptx
RT in early breast.pptx
Sheedh4
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Bharat Mistary
 
FAST FORWARD.pptx
FAST FORWARD.pptxFAST FORWARD.pptx
FAST FORWARD.pptx
Kiron G
 
March meta analysis updated result
March meta analysis  updated resultMarch meta analysis  updated result
March meta analysis updated result
Parag Roy
 
Radiotherapy plan evaluation in brain tumours
Radiotherapy plan evaluation in brain tumoursRadiotherapy plan evaluation in brain tumours
Radiotherapy plan evaluation in brain tumours
Ashutosh Mukherji
 
IMPORT-HIGH.pptx
IMPORT-HIGH.pptxIMPORT-HIGH.pptx
IMPORT-HIGH.pptx
Kiron G
 
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
Todd Scarbrough
 

Similar to Forward imrt in breast radiotherapy (20)

Accelerated partial breast irradiation
Accelerated partial breast irradiationAccelerated partial breast irradiation
Accelerated partial breast irradiation
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiation
 
Apbi
ApbiApbi
Apbi
 
Overview of ART in lung cancer
Overview of ART in lung cancerOverview of ART in lung cancer
Overview of ART in lung cancer
 
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approach
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approachImmobilization and setup for Prone Breast Radiotherapy- A Therapist approach
Immobilization and setup for Prone Breast Radiotherapy- A Therapist approach
 
Adjuvant radiotherapy of regional lymph nodes in breast
Adjuvant radiotherapy of regional lymph nodes in breastAdjuvant radiotherapy of regional lymph nodes in breast
Adjuvant radiotherapy of regional lymph nodes in breast
 
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
 
MOULD BRACHYTHERAPY LIP
MOULD BRACHYTHERAPY LIPMOULD BRACHYTHERAPY LIP
MOULD BRACHYTHERAPY LIP
 
Radiotherapy Breast Cancer
Radiotherapy Breast CancerRadiotherapy Breast Cancer
Radiotherapy Breast Cancer
 
Cervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniquesCervix External Beam Radiotherapy techniques
Cervix External Beam Radiotherapy techniques
 
hypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptxhypofractionationinbreastexperiment.pptx
hypofractionationinbreastexperiment.pptx
 
Unscheduled rt interruptions
Unscheduled rt interruptionsUnscheduled rt interruptions
Unscheduled rt interruptions
 
Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast Cancer
 
RT in early breast.pptx
RT in early breast.pptxRT in early breast.pptx
RT in early breast.pptx
 
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
 
FAST FORWARD.pptx
FAST FORWARD.pptxFAST FORWARD.pptx
FAST FORWARD.pptx
 
March meta analysis updated result
March meta analysis  updated resultMarch meta analysis  updated result
March meta analysis updated result
 
Radiotherapy plan evaluation in brain tumours
Radiotherapy plan evaluation in brain tumoursRadiotherapy plan evaluation in brain tumours
Radiotherapy plan evaluation in brain tumours
 
IMPORT-HIGH.pptx
IMPORT-HIGH.pptxIMPORT-HIGH.pptx
IMPORT-HIGH.pptx
 
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
 

More from Nilesh Kucha

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Nilesh Kucha
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
Nilesh Kucha
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
Nilesh Kucha
 
Chapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer preventionChapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer prevention
Nilesh Kucha
 
Chapter 37 svco
Chapter 37 svcoChapter 37 svco
Chapter 37 svco
Nilesh Kucha
 
Chapter 36 t reg cells
Chapter 36 t reg cellsChapter 36 t reg cells
Chapter 36 t reg cells
Nilesh Kucha
 
Chapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndromeChapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndrome
Nilesh Kucha
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
Nilesh Kucha
 
Chapter 33 isolated tumor cells
Chapter 33 isolated tumor cellsChapter 33 isolated tumor cells
Chapter 33 isolated tumor cells
Nilesh Kucha
 
Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasis
Nilesh Kucha
 
Chapter 31 genetic counselling
Chapter 31 genetic counsellingChapter 31 genetic counselling
Chapter 31 genetic counselling
Nilesh Kucha
 
Chapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaChapter 30 febrile neutropenia
Chapter 30 febrile neutropenia
Nilesh Kucha
 
Chapter 29 dendritic cells
Chapter 29 dendritic cellsChapter 29 dendritic cells
Chapter 29 dendritic cells
Nilesh Kucha
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials
Nilesh Kucha
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
Nilesh Kucha
 
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerChapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
Nilesh Kucha
 
Chapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responsesChapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responses
Nilesh Kucha
 
Chapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyChapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapy
Nilesh Kucha
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosis
Nilesh Kucha
 
Chapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodiesChapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodies
Nilesh Kucha
 

More from Nilesh Kucha (20)

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
 
Chapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer preventionChapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer prevention
 
Chapter 37 svco
Chapter 37 svcoChapter 37 svco
Chapter 37 svco
 
Chapter 36 t reg cells
Chapter 36 t reg cellsChapter 36 t reg cells
Chapter 36 t reg cells
 
Chapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndromeChapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndrome
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
 
Chapter 33 isolated tumor cells
Chapter 33 isolated tumor cellsChapter 33 isolated tumor cells
Chapter 33 isolated tumor cells
 
Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasis
 
Chapter 31 genetic counselling
Chapter 31 genetic counsellingChapter 31 genetic counselling
Chapter 31 genetic counselling
 
Chapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaChapter 30 febrile neutropenia
Chapter 30 febrile neutropenia
 
Chapter 29 dendritic cells
Chapter 29 dendritic cellsChapter 29 dendritic cells
Chapter 29 dendritic cells
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
 
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerChapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
 
Chapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responsesChapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responses
 
Chapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyChapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapy
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosis
 
Chapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodiesChapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodies
 

Recently uploaded

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Forward imrt in breast radiotherapy

  • 1. FORWARD IMRT DR. AMRITA RAKESH DNB RESIDENT DEPT. OF RADIATION ONCOLOGY BMCHRC,JAIPUR.
  • 2. Introduction • Prime objective for the planning : to deliver uniform dose throughout the target volume, with adequate tumour coverage and minimise dose to normal tissue. • Evolution of treatment planning : conventional to 3D conformal to IMRT. • Most patients with early breast cancer undergo breast- conserving treatment consisting of wide excision and post- operative whole-breast radiotherapy. This form of postoperative radiotherapy reduces the risk of local recurrence and results in long-term survival similar to that obtained with mastectomy. • Thus, postoperative breast therapy is a standard treatment
  • 3. • In recent years, the field-in-field (FIF) technique (i.e., Forward IMRT) has become a widely performed method of administering tangential whole-breast radiotherapy. • The use of the FIF technique permits reductions in the size of the high-dose region and better homogeneity index.
  • 4. Why homogeneity Matters? Whole breast irradiation often leads to both acute and long term toxicities such as : • moist desquamation • pain • breast discomfort • breast hardness Many studies shown that toxicities were associated with dose inhomogeneity (hot spots).
  • 5. • Pignol et al 358 patients were randomized in a multicenter double-blind clinical trial to either 2-dimentional treatment planning or IMRT planning with improved dose homogeneity. The incidence of moist desquamation in the IMRT group was 31.2% vs 47.8%, p=0.002 Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008 May 1;26(13):2085-92.
  • 6. • Donovan et al 306 patients were randomized to 2D or 3D IMRT. After 5 years 240 patients data was available for analysis. The 2D arm patients were 1.7 times more likely to have changes in breast appearance than IMRT group Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol. 2007 Mar;82(3):254- 64.
  • 7. Breast V105% and V110% were significantly associated with increase in acute skin toxicity • V110% < 200cc: 31% grade >2 skin toxicity • V110% > 200cc: 61% grade >2 skin toxicity Vicini et.al. Int.J. Radiat Oncol Biol Phys 54: 1336-1344; 2002.
  • 8. • The use of IMRT in the treatment of the whole breast results in a significant decrease in acute dermatitis, edema, and hyperpigmentation and a reduction in the development of chronic breast edema compared with conventional wedge-based WBRT. Harsolia et.al. Int.J. Radiat Oncol Biol Phys 68: 1375-1380; 2007
  • 9. • Inverse Planning: The user specifies the goals, the computer then adjusts the beam parameters to achieve the desired outcome. • Forward Planning: The beam geometry i.e beam angle, shape, modifier, weights etc. is first defined, followed by calculation of the 3D dose distribution.
  • 10. IMRT for Breast Radiotherapy Many beams with different angles may help with dose conformality, but will lead to higher doses in lung, heart and contralateral breast Tangential beams provide best lung, heart and contralateral breast sparing.
  • 11.
  • 12. FIELD-IN-FIELD TECHNIQUE • Comprises of two tangential open fields and multiple subfields to achieve desired homogeneity. • An open beam configuration is first calculated and evaluated. • 4+ subfields per gantry angle are used to produce an optimal breast plan. • No wedges. FORWARD PLANNING
  • 13. Subfields • Generally have 1 lung block and 3 additional subfields per gantry angle. • Lung block is formed by fitting the MLC’s to the shape of the lung. Aids in lateral hot spots. • Additional subfields are generated by manually fitting MLC’s to “hot” areas. Ex. 115%, 110%, etc…
  • 14. • Lung block • manual fitting of MLC’s to “hot” areas
  • 15. Weighting of Subfields • Generally, the open beam portion receives ~ 80% of the dose while the subfields contribute ~20%. • This makes FP IMRT similar to conventional treatment . • Minimizes effects of patient movement on target coverage. • Conventional breast plans are generally normalized to 97% . • Normalization for IMRT plans are based on coverage.
  • 16. Determination of the optimal method for the field-in-field technique in breast tangential radiotherapy Hidekazu Tanaka, Shinya Hayashi, and Hiroaki Hoshi J Radiat Res. 2014 Jul; 55(4): 769–773. • Several studies have reported the usefulness of the field-in-field (FIF) technique in breast radiotherapy. However, the methods for the FIF technique used in these studies vary. • There were no reports of comparisons among FIF techniques.
  • 17. • This study, classified the methods used for the FIF technique into three categories : • The single pair of subfields method - • In the SSM, each main field was copied as a pair of subfields. • The MLCs were manipulated to shield the areas of the breast receiving any dose (mainly at 105–107% of the prescription dose). • The dose to shield the MLCs was determined such that the isodose cloud disappears. • This method was composed of four fields, including the main fields.
  • 18. • The multiple pairs of subfields method - • Three pairs of subfields were generated. • The MLCs were set to block the dose level at 1– 2% lower than the maximum dose (Dmax), and this was followed by a 3–5% dose reduction (mainly at 102–105% of the prescription dose). • This method comprised eight fields, including the main fields.
  • 19. • The alternate subfields method - • First, the medial main field was copied as the first subfield. • The MLCs were set to block the dose level at 1–2% lower than the Dmax. • Dose calculation was performed. The beam weight of this subfield was added until the dose cloud disappeared.
  • 20. • Second, the lateral main field was copied as the second subfield. • The MLCs were set to block the dose level at 2– 3% lower than the dose blocked at the first subfield. • Dose calculation was performed again, and the beam weight of this subfield was added until the dose cloud disappeared.
  • 21. • Finally, the medial main field was copied again as the third subfield. • The MLCs were set to block the dose level at 2–3% lower than the dose blocked at the second subfield. • After recalculation, the beam weight of this subfield was added until the dose cloud disappeared. • This method was comprised of five fields, including the main fields.
  • 22.
  • 23. Beam's eye view for typical subfield. The subfield was manipulated to shield the areas of the breast receiving any dose cloud.
  • 24. • The Dmax to the PTV and the volumes of the PTV receiving 100% and 95% of the prescription dose (V100% and V95%, respectively) were calculated. • The homogeneity index (HI) was calculated.
  • 25. • RESULTS: • This planning study included 51 patients with early stage breast cancer: 20 with right-sided breast cancer and 31 with left-sided breast cancer. • The median age of the patients was 53 years (range, 26–76 years).
  • 26. Table Average of dose parameters of PTV for each method SSM (± SD) MSM (± SD) ASM (± SD) Dmax 52.5 (± 0.7)52.2 (± 0.6)52.2 (± 0.7) V100% 52.6 (± 16.7) 48.7 (± 14.9) 60.3 (± 14.2) V95% 93.7 (± 4.2)93.2 (± 4.1)94.1 (± 3.5) • The average V100% with ASM was significantly higher than that with SSM and MSM
  • 27. • The ASM outperformed the SSM and MSM for two possible reasons: • First is that the number of subfields used is more suitable for the population under study. When the number of subfields is large, the dose to the PTV decreases, but when the number of subfields is small, the full range of advantages of the FIF cannot be fully obtained. • The biggest advantage of the ASM is its ability to perform dose calculation each time a subfield is added.
  • 28. Key note : • Radiotherapy planning with SSM required a relatively short time, because only a few subfields need to be generated. • Because SSM is the simplest of the three methods, it should be the method of choice for patients with small breasts. • The method most commonly reported is the one in which multiple pairs of subfields are used. This method was classified as MSM. The planning time is longer for this method because of the high number of subfields.
  • 29. • MD Anderson Cancer Centre group introduced in terms of number of subfields, fewer subfields than MSM but more than SSM. This method was classified as ASM. • The most significant feature of this method is the recalculation each time when creating subfields, and the addition of subfields alternately. • Of note, patients in the thin breast group derived similar benefit with ASM and SSM. • ASM resulted in better dose distribution regardless of the breast size.
  • 30. Nagoya J. Med. Sci. 77. 339 ~ 345, 2015 Evaluation of the field-in-field technique with lung blocks for breast tangential radiotherapy Hidekazu Tanaka et al. • This study evaluated the FIF technique with lung blocks for breast tangential radiotherapy. • Compared to irradiation with physical wedges (PWs), the use of the FIF technique permits reductions in the size of the high-dose region. • The impact of respiratory motion is smaller with the use of the FIF technique than with the use of PWs.
  • 31. • Several authors reported the advantages of lung- blocked subfields, which help to reduce the dose received by the lungs. • However, the use of multileaf collimators (MLCs) to block the lungs also results in blockade of some parts of the planning target volume (PTV). This could decrease the doses delivered to the PTV. • In this study,16 patients with early-stage breast cancer, including 9 patients with right-sided cancer and 7 patients with left-sided breast cancer.
  • 32. • Two opposed tangential fields were created without PWs. • The open field was copied as the subfields & on the beam’s eye view, the MLCs were set to block the hotspots. • Then, dose calculation was performed. The beam weight of this subfield was increased until the dose cloud disappeared.
  • 33.
  • 34.
  • 35. • The volumes of the ipsilateral lung receiving 20, 30, and 40 Gy (V20Gy, V30Gy, and V40Gy, respectively) were calculated. • The volumes of the PTV receiving 100 and 95% of the prescription dose (V100% and V95%, respectively) and the mean dose (Dmean) to the PTV were also calculated. • The amounts of change in the FIF plan and PWs were evaluated.
  • 36. • In this study, lung blocks were useful for reducing the dose delivered to the lungs, but a simultaneous decrease in the PTV was observed. • FIF plan was advantageous over the use of physical wedges.
  • 37.
  • 38. ique by comparing it with the electronic compensator, varian enh
  • 39.
  • 40. (a) Main field without multileaf collimator (MLC) blocking. (b)drawing MLCs to block 112 % isodose cloud (c) drawing MLCs to block out 106 % (d) drawing MLCs to block out 102%
  • 41. FIF gave favourable results for all aspects when compared with other plans.
  • 42. The “skin flash” problem in Inverse Problem • Conventional : margin added to field edge to allow for uncertainties. • IMRT : intensity remains “zero” outside PTV. No skin flash
  • 43. • So, previously tissue equivalent material where added during planning over the breast, and then plan were made. So, in actual setup, when MLCs opened up, actual PTV used to be in air.
  • 44. • But now, after forward planning, MLCs are opened to desired width in air, to allow “skin flash”.
  • 45.
  • 46. • To sum up: • Conformality adaptions are limited • Tangential beams are used for main field , as increasing number of beams will increase lung dose. • As main field is copied and subfields created to adjust beam parameters,and then we do dose calculation- so, it is forward planning. • Dose homogeneity is improved. • Less time taking. • Simple planning.
  • 47. THANK YOU… Next Topic : APBI by Dr. Shuchita